Form 4 for TMDX TransMedics Group, Inc.
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-24 · accession 0000950170-25-028048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-26 | 2025-02-24 | TMDX | Ranganath Anil P. | See remarks | A - Grant | $0.00 | +5,634 | 14.6K | +63% | $0 |
| D | 2025-02-26 | 2025-02-24 | TMDX | Ranganath Anil P. | See remarks | A - Grant | $0.00 | +8,479 | 8,479 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-24 | A | A | 5,634 | $0.00 | 14,641 | D | — | — | (F1) Consists of 5,634 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. (F2) Includes 114 shares of Issuer's Common Stock acquired on December 31, 2024, pursuant to the TransMedics Group, Inc. 2019 Employee Stock Purchase Plan ("ESPP"), for the option period of July 1, 2024 to December 31, 2024. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-24 | A | A | 8,479 | $0.00 | 8,479 | D | $77.12 · — to 2035-02-24 | 8,479 Common Stock | (F3) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service. |